LGR5 Promotes Breast Cancer Progression and Maintains Stem‐Like Cells Through Activation of Wnt/β‐Catenin Signaling
暂无分享,去创建一个
Hailin Tang | Lu Yang | Y. Kong | Jianping Chen | Xiaoping Liu | Hailin Tang | Xiaoming Xie | Ning Li | Jianping Chen | Xiaoping Liu | Xiaoming Xie | Lu Yang | Feng Ye | Xinhua Xie | Feng Ye | Yanan Kong | Xinhua Xie | Cailu Song | Ning Li | Neng Wang | Cailu Song | Neng Wang | Neng Wang | Neng Wang
[1] R. Nusse,et al. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.
[2] Xiaoping Liu,et al. miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.
[3] J. Visvader,et al. Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.
[4] S. Hirohashi,et al. Overexpression of orphan G‐protein–coupled receptor, Gpr49, in human hepatocellular carcinomas with β‐catenin mutations , 2003, Hepatology.
[5] Hans Clevers,et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. , 2010, Cell stem cell.
[6] Ophir D Klein,et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. , 2013, Cell reports.
[7] H. Taubert,et al. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients , 2011, BMC Cancer.
[8] Edi Brogi,et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.
[9] R. Margolskee,et al. Lgr5‐EGFP Marks Taste Bud Stem/Progenitor Cells in Posterior Tongue , 2013, Stem cells.
[10] François Vaillant,et al. Generation of a functional mammary gland from a single stem cell , 2006, Nature.
[11] Chi-Hung Huang,et al. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways. , 2014, European journal of cancer.
[12] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[14] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[15] H. Clevers,et al. Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. , 2012, Cell reports.
[16] Hans Clevers,et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.
[17] B. Zhou,et al. New insights of epithelial-mesenchymal transition in cancer metastasis. , 2008, Acta biochimica et biophysica Sinica.
[18] A. Burgess,et al. LGR5 Is a Negative Regulator of Tumourigenicity, Antagonizes Wnt Signalling and Regulates Cell Adhesion in Colorectal Cancer Cell Lines , 2011, PloS one.
[19] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[20] Hans Clevers,et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.
[21] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[22] N. Koizumi,et al. Corneal Endothelial Cell Fate Is Maintained by LGR5 Through the Regulation of Hedgehog and Wnt Pathway , 2013, Stem cells.
[23] Min Deng,et al. miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression , 2013, Clinical Cancer Research.
[24] R. Nusse,et al. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. , 2010, Cell stem cell.
[25] T. Nishikawa,et al. Tumorigenesis and Neoplastic Progression G-Protein-Coupled Receptor GPR 49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation , 2010 .
[26] O. Er,et al. Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.
[27] G. Mills,et al. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. , 2008, Cancer research.
[28] E. Neilson,et al. Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.
[29] Y. Matsuno,et al. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. , 2011, Anticancer Research.
[30] A. Rocha,et al. Distinct stem cells contribute to mammary gland development and maintenance , 2011, Nature.
[31] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[32] H. Ruffner,et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner , 2012, Nature.
[33] Jane E. Visvader,et al. In situ identification of bipotent stem cells in the mammary gland , 2014, Nature.
[34] C. Cruciat,et al. LGR4 and LGR5 are R‐spondin receptors mediating Wnt/β‐catenin and Wnt/PCP signalling , 2011, EMBO reports.
[35] H. Beug,et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.
[36] Charis Eng,et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. , 2008, Cancer research.
[37] Kathleen M. Smith,et al. Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors , 2006, Cancer biology & therapy.
[38] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions: insights from development , 2012, Development.
[39] H. Clevers,et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.
[40] Hans Clevers,et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.
[41] Hans Clevers,et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells , 2008, Nature Genetics.
[42] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[43] Q. Lin,et al. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling , 2011, Proceedings of the National Academy of Sciences.
[44] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[45] T. Taguchi,et al. Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers , 2009, Clinical Cancer Research.
[46] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[47] J. Reis-Filho,et al. Epithelial and Mesenchymal Subpopulations Within Normal Basal Breast Cell Lines Exhibit Distinct Stem Cell/Progenitor Properties , 2012, Stem cells.
[48] Gabriela Vasile,et al. Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. , 2013, Cell reports.
[49] K. Cadigan. Faculty of 1000 evaluation for Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. , 2017 .
[50] M. Loeffler,et al. Lgr5(+) gastric stem cells divide symmetrically to effect epithelial homeostasis in the pylorus. , 2013, Cell reports.